131 related articles for article (PubMed ID: 12437088)
1. Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics.
Overall CM; McQuibban GA; Clark-Lewis I
Biol Chem; 2002; 383(7-8):1059-66. PubMed ID: 12437088
[TBL] [Abstract][Full Text] [Related]
2. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.
Overall CM; Tam EM; Kappelhoff R; Connor A; Ewart T; Morrison CJ; Puente X; López-Otín C; Seth A
Biol Chem; 2004 Jun; 385(6):493-504. PubMed ID: 15255181
[TBL] [Abstract][Full Text] [Related]
3. [Type IV collagenases (MMP-2 and MMP-9) and their substrates--intracellular proteins, hormones, cytokines, chemokines and their receptors].
Hrabec E; Naduk J; Strek M; Hrabec Z
Postepy Biochem; 2007; 53(1):37-45. PubMed ID: 17718386
[TBL] [Abstract][Full Text] [Related]
4. The matrix metalloproteinase stromelysin-3 cleaves laminin receptor at two distinct sites between the transmembrane domain and laminin binding sequence within the extracellular domain.
Amano T; Kwak O; Fu L; Marshak A; Shi YB
Cell Res; 2005 Mar; 15(3):150-9. PubMed ID: 15780176
[TBL] [Abstract][Full Text] [Related]
5. Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases.
Cauwe B; Opdenakker G
Crit Rev Biochem Mol Biol; 2010 Oct; 45(5):351-423. PubMed ID: 20812779
[TBL] [Abstract][Full Text] [Related]
6. [Matrix metalloproteinases and their inhibitors, modulators of neuro-immune interactions and of pathophysiological processes in the nervous system].
Khrestchatisky M; Jourquin J; Ogier C; Charton G; Bernard A; Tremblay E; Rivera S
J Soc Biol; 2003; 197(2):133-44. PubMed ID: 12910628
[TBL] [Abstract][Full Text] [Related]
7. Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP).
Osenkowski P; Toth M; Fridman R
J Cell Physiol; 2004 Jul; 200(1):2-10. PubMed ID: 15137052
[TBL] [Abstract][Full Text] [Related]
8. Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates.
Tam EM; Morrison CJ; Wu YI; Stack MS; Overall CM
Proc Natl Acad Sci U S A; 2004 May; 101(18):6917-22. PubMed ID: 15118097
[TBL] [Abstract][Full Text] [Related]
9. Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics.
Butler GS; Overall CM
Biochemistry; 2009 Nov; 48(46):10830-45. PubMed ID: 19817485
[TBL] [Abstract][Full Text] [Related]
10. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation.
Van Lint P; Libert C
J Leukoc Biol; 2007 Dec; 82(6):1375-81. PubMed ID: 17709402
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase proteomics: substrates, targets, and therapy.
Morrison CJ; Butler GS; Rodríguez D; Overall CM
Curr Opin Cell Biol; 2009 Oct; 21(5):645-53. PubMed ID: 19616423
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites.
Overall CM
Mol Biotechnol; 2002 Sep; 22(1):51-86. PubMed ID: 12353914
[TBL] [Abstract][Full Text] [Related]
13. Membrane type-matrix metalloproteinases and tumor progression.
Sounni NE; Noel A
Biochimie; 2005; 87(3-4):329-42. PubMed ID: 15781320
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix remodelling: the role of matrix metalloproteinases.
Stamenkovic I
J Pathol; 2003 Jul; 200(4):448-64. PubMed ID: 12845612
[TBL] [Abstract][Full Text] [Related]
15. Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates.
Cauwe B; Martens E; Proost P; Opdenakker G
Integr Biol (Camb); 2009 Jun; 1(5-6):404-26. PubMed ID: 20023747
[TBL] [Abstract][Full Text] [Related]
16. Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer.
Overall CM; Dean RA
Cancer Metastasis Rev; 2006 Mar; 25(1):69-75. PubMed ID: 16680573
[TBL] [Abstract][Full Text] [Related]
17. Chemokine degradation by the Group A streptococcal serine proteinase ScpC can be reconstituted in vitro and requires two separate domains.
Fritzer A; Noiges B; Schweiger D; Rek A; Kungl AJ; von Gabain A; Nagy E; Meinke AL
Biochem J; 2009 Aug; 422(3):533-42. PubMed ID: 19552626
[TBL] [Abstract][Full Text] [Related]
18. The effects of exosite occupancy on the substrate specificity of thrombin.
Ng NM; Quinsey NS; Matthews AY; Kaiserman D; Wijeyewickrema LC; Bird PI; Thompson PE; Pike RN
Arch Biochem Biophys; 2009 Sep; 489(1-2):48-54. PubMed ID: 19638274
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1.
McQuibban GA; Butler GS; Gong JH; Bendall L; Power C; Clark-Lewis I; Overall CM
J Biol Chem; 2001 Nov; 276(47):43503-8. PubMed ID: 11571304
[TBL] [Abstract][Full Text] [Related]
20. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.
McQuibban GA; Gong JH; Tam EM; McCulloch CA; Clark-Lewis I; Overall CM
Science; 2000 Aug; 289(5482):1202-6. PubMed ID: 10947989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
